Page 478 - Binder2

(pg. 71) Reuters. (2022, August 2). AbbVie wins appeal in
antitrust case over Humira patent thicket.
https://www.reuters.com/legal/litigation/abbvie-wins-
appeal-antitrust-case-over-humira-patent-thicket-2022-08-
02/

(pg, 74) The Lancet Rheumatology. (2023).
https://www.thelancet.com/journals/lanrhe/article/PIIS2665
-9913%2823%2900341-7/abstract

(pg. 139) NCH Stats. (n.d.). Average cost of hospital stays
in the US. https://nchstats.com/average-cost-of-hospital-
stays-in-us/

(pg. 59) AHIP. (n.d.). New study: 7 out of 10 big pharma
companies spent more on sales and marketing than R&D.
https://www.ahip.org/news/articles/new-study-in-the-midst-
of-covid-19-crisis-7-out-of-10-big-pharma-companies-
spent-more-on-sales-and-marketing-than-r-d

(pg. 59) BioSpace. (n.d.). Biologics market size to hit
around USD 1.37 trillion by 2033.
https://www.biospace.com/biologics-market-size-to-hit-
around-usd-1-37-trillion-by-2033

(pg. 74) National Conference of State Legislatures. (n.d.).
Decreasing drug costs through generics and biosimilars.
https://www.ncsl.org/health/decreasing-drug-costs-through-
generics-and-biosimilars

(pg. 66) Gallup. (n.d.). Retail pharmaceutical industry's
slip in public esteem.
https://news.gallup.com/poll/510641/retail-pharmaceutical-
industries-slip-public-esteem.aspx

476